Publication | Closed Access

A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia

ThrombopoiesisThrombosisVenous ThrombosisAutoimmune DiseaseBlood PlateletControlled TrialPrimary Immune ThrombocytopeniaImmunologyClinical TrialsHematologyPlatelet AntagonistAutoimmunityImmunotherapyMedicineAnticoagulantHealth Sciences